163 related articles for article (PubMed ID: 2287793)
21. [The study of chemical mediators in the patients with allergic rhinitis 2). Histamine, leukotriene and kinins in the nasal secretion during dual phase response].
Kojima T; Asakura K
Nihon Jibiinkoka Gakkai Kaiho; 1991 Mar; 94(3):366-76. PubMed ID: 2040914
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptides and nasal secretion.
Baraniuk JN; Kaliner M
Am J Physiol; 1991 Oct; 261(4 Pt 1):L223-35. PubMed ID: 1928355
[TBL] [Abstract][Full Text] [Related]
23. Chronic rhinosinusitis and neuropeptides.
Lacroix JS
Swiss Med Wkly; 2003 Nov; 133(41-42):560-2. PubMed ID: 14691727
[TBL] [Abstract][Full Text] [Related]
24. Comparison of human nasal mucosal secretion in vivo and in vitro.
Mullol J; Raphael GD; Lundgren JD; Baraniuk JN; Mérida M; Shelhamer JH; Kaliner MA
J Allergy Clin Immunol; 1992 Feb; 89(2):584-92. PubMed ID: 1740587
[TBL] [Abstract][Full Text] [Related]
25. The mechanisms involved in onset of allergic manifestations in the nose.
Konno A; Togawa K; Fujiwara T
Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():155-66. PubMed ID: 6193990
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptides and nasal secretion.
Baraniuk JN; Kaliner MA
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):620-7. PubMed ID: 2229824
[TBL] [Abstract][Full Text] [Related]
27. Impaired norepinephrine-mediated contraction of isolated nasal mucosa in guinea pigs with allergic rhinitis.
Chiba Y; Matsuo K; Sakai H; Misawa M
Am J Rhinol; 2006; 20(4):477-9. PubMed ID: 16955783
[TBL] [Abstract][Full Text] [Related]
28. Histamine H3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa.
Varty LM; Hey JA
Eur J Pharmacol; 2002 Oct; 452(3):339-45. PubMed ID: 12359275
[TBL] [Abstract][Full Text] [Related]
29. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis.
Knani J; Campbell A; Enander I; Peterson CG; Michel FB; Bousquet J
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 1):880-9. PubMed ID: 1334102
[TBL] [Abstract][Full Text] [Related]
30. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
Raphael GD; Igarashi Y; White MV; Kaliner MA
J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
[TBL] [Abstract][Full Text] [Related]
31. The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis.
Takahashi G; Tanaka H; Higuchi N; Ikeda M; Inagaki N; Shichijo M
Int Arch Allergy Immunol; 2012; 158(4):359-68. PubMed ID: 22472859
[TBL] [Abstract][Full Text] [Related]
32. Unique mechanistic features of allergic rhinitis.
Togias A
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 2):S599-604. PubMed ID: 10856164
[TBL] [Abstract][Full Text] [Related]
33. Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects.
Baraniuk JN; Clauw D; Yuta A; Ali M; Gaumond E; Upadhyayula N; Fujita K; Shimizu T
Am J Rhinol; 1998; 12(6):435-40. PubMed ID: 9883301
[TBL] [Abstract][Full Text] [Related]
34. Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs.
Abe Y; Takeda N; Irifune M; Ogino S; Kalubi B; Imamura I; Fukui H; Wada H; Matsunaga T
Acta Otolaryngol; 1992; 112(4):703-9. PubMed ID: 1279933
[TBL] [Abstract][Full Text] [Related]
35. Nasal Mucosal Expression of the Receptors for Inflammatory Chemical Mediators.
Shirasaki H; Saikawa E; Seki N; Kikuchi M; Himi T
Adv Otorhinolaryngol; 2016; 77():52-8. PubMed ID: 27116229
[TBL] [Abstract][Full Text] [Related]
36. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin.
Lacroix JS; Buvelot JM; Polla BS; Lundberg JM
Clin Exp Allergy; 1991 Sep; 21(5):595-600. PubMed ID: 1742652
[TBL] [Abstract][Full Text] [Related]
37. Upper airway neurogenic mechanisms.
Tai CF; Baraniuk JN
Curr Opin Allergy Clin Immunol; 2002 Feb; 2(1):11-9. PubMed ID: 11964745
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of airflow limitation in the nose and lungs.
Dahl R; Mygind N
Clin Exp Allergy; 1998 Jun; 28 Suppl 2():17-25. PubMed ID: 9678823
[TBL] [Abstract][Full Text] [Related]
39. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
40. Vascular effects of topically applied bradykinin on the human nasal mucosa.
Holmberg K; Bake B; Pipkorn U
Eur J Pharmacol; 1990 Jan; 175(1):35-41. PubMed ID: 2323344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
